Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-05-15 HERSHBERG ROBERT Director Sale −398 $36.10 $14K 0
2020-05-15 HERSHBERG ROBERT Director Option exercise · Stock Option (Right to Buy) −2,000 73,000
2020-05-15 ROBINS HARLAN S Chief Scientific Officer Option exercise +35,400 $6.32 $224K 106,079
2020-05-15 ROBINS HARLAN S Chief Scientific Officer Sale −100 $33.56 $3K 105,979
2020-05-15 ROBINS HARLAN S Chief Scientific Officer Sale −400 $35.13 $14K 105,579
2020-05-15 ROBINS HARLAN S Chief Scientific Officer Sale −5,400 $36.34 $196K 100,179
2020-05-15 ROBINS HARLAN S Chief Scientific Officer Sale −22,342 $37.53 $838K 77,837
2020-05-15 ROBINS HARLAN S Chief Scientific Officer Sale −7,158 $38.11 $273K 70,679
2020-05-15 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −35,400 444,600
2020-05-15 SANG CHARLES SVP, Clinical Diagnostics Option exercise +20,000 $6.32 $126K 20,000
2020-05-15 SANG CHARLES SVP, Clinical Diagnostics Option exercise +20,000 $6.55 $131K 40,000
2020-05-15 SANG CHARLES SVP, Clinical Diagnostics Sale −40,000 $38.01 $1.5M 0
2020-05-15 SANG CHARLES SVP, Clinical Diagnostics Option exercise · Stock Option (Right to Buy) −20,000 80,000
2020-05-15 SANG CHARLES SVP, Clinical Diagnostics Option exercise · Stock Option (Right to Buy) −20,000 230,000
2020-05-14 ROBINS HARLAN S Chief Scientific Officer Option exercise +31,200 $6.32 $197K 101,879
2020-05-14 ROBINS HARLAN S Chief Scientific Officer Sale −3,200 $34.26 $110K 98,679
2020-05-14 ROBINS HARLAN S Chief Scientific Officer Sale −28,000 $35.44 $992K 70,679
2020-05-14 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −31,200 480,000
2020-05-12 RUBINSTEIN JULIE President Option exercise +30,000 $0.84 $25K 30,000
2020-05-12 RUBINSTEIN JULIE President Sale −24,860 $38.20 $950K 5,140

Page 106 of 120 · 2,386 trades